AstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted the drug could cause very ...

AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate ...

May 2 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma ...

CAMBRIDGE, Britain — CAMBRIDGE, Britain — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company said it ...

LONDON, April 29 (Reuters) - The chief executive of AstraZeneca (AZN.L), opens new ... Europe reviews Valneva's chikungunya vaccine after reports of serious side effects 4:33 PM UTC · Updated ...

European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a ...

as locked contentWangmo Kira vaccine, Oxford-AstraZeneca locked contentobserve. wons as adverse locked contentvaccine, Dzong Oxford-AstraZeneca in locked contentas Tshechu adverse it locked ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of annual sales of $3 billion to $5 billion for the 3-in-1 inhaler.

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 billion. However many analysts felt the company had paid far too much ...

That’s basically what has to change.” AstraZeneca last year axed plans for a £450m vaccine factory in Liverpool Credit: Paul Ellis/AFP AstraZeneca last year axed plans for a £450m vaccine ...